Life Extension Magazine September 2006
Why Aging Humans Need More Carnitine
By Julius G. Goepp, MD
An inevitable consequence of aging is a rapid decline in our cellular energy levels. The outward effects often manifest as a sense of overall fatigue, depression, and sexual dysfunction. The internal effect of a cellular energy deficit is a greater vulnerability to a host of degenerative diseases.
The prime reason cells lose their energy-producing ability is that the powerhouses of the cells—the mitochondria—become dysfunctional. Research has shown that the amino acid carnitine is critical to maintaining optimal mitochondrial function and supporting high energy production.
Carnitine is responsible for fueling the fires of energy production at the cellular level. Without this valuable nutrient, the mitochondria are unable to burn dietary fats to create the energy we need to live.
Scientists have discovered several different forms of carnitine that, in addition to bolstering energy production, produce health benefits that include protecting against neurodegenerative diseases, alleviating depression, stimulating nerve growth, and improving heart function.
Why Carnitine Supplementation Is Essential
During one’s youth, most of the body’s requirement for carnitine is met by internal production of carnitine from lysine, as well as by dietary sources such as red meat and dairy products.1 An increasing body of evidence, however, indicates that to obtain enough carnitine to secure its protective effects against aging requires supplementation in addition to dietary sources.2
While scientific studies initially focused on the simplest form of carnitine, known as L-carnitine, recent findings suggest that specialized carnitine formulations may provide more dramatic, tissue-specific benefits.3
Acetyl-L-carnitine is the most widely studied carnitine supplement. It readily crosses the blood-brain barrier4 and thus confers powerful protective effects on nerve tissue and the central nervous system—enhancing mood, restoring energy, and alleviating nerve pain.
A closely related compound, acetyl-L-carnitine arginate, combines carnitine with the amino acid arginine. It appears to have the same general properties as acetyl-L-carnitine, with the additional benefit of increasing nerve cell growth, thus making it a promising agent in addressing neurodegenerative conditions and possibly trauma.
Finally, propionyl-L-carnitine is a form of carnitine that appears to have potent effects in cardiac and skeletal muscle,3 giving it a potential role in maintaining physical energy and stamina.
This article will examine the complementary roles of these different forms of carnitine and how readers can select carnitine supplements to address their specific health concerns associated with aging.
Acetyl-L-Carnitine Benefits Brain and Nerve Function
Because acetyl-L-carnitine is absorbed from the intestinal tract and readily crosses the blood-brain barrier,4,10,11 it has been studied extensively for its role in brain and nerve functions. Some of the most compelling data are summarized here, according to the kinds of conditions involved.
Slowing Alzheimer’s and Neurodegenerative Diseases
Our brains require vast amounts of energy to function on a daily basis. The long-term effect of this high energy consumption is a kind of “brain rust,” or oxidative damage to mitochondria in the brain. This cellular damage is thought to be an important factor in brain aging and neurodegenerative diseases.12 Protecting brain cells from oxidative damage is one of the most important ways to ensure optimal brain function.
Interestingly, scientific data suggest that acetyl-L-carnitine affects the function of nerve growth factor, a protein that promotes the growth and development of both central and peripheral nerve cells.13 Acetyl-L-carnitine prevents stress-related reductions in nerve growth factor levels, and prevents the death of brain cells in culture.13,14 These mechanisms may explain how it reduces damage to brain cells caused by the amyloid beta peptide, which is found in the brains of patients with Alzheimer’s disease and other neurodegenerative conditions.15-17
Recent well-designed human trials support the use of acetyl-L-carnitine in managing Alzheimer’s disease. In a double-blind, placebo-controlled study of 334 Alzheimer’s patients conducted in 1998, a significant slowing of disease progression was demonstrated in those who supplemented with acetyl-L-carnitine.18 Similar results were found in a small trial of seven Alzheimer’s patients, which showed that acetyl-L-carnitine supplementation led to less deterioration of mental status.19 As a result of these studies, researchers are now conducting larger studies examining acetyl-L-carnitine’s benefits for people suffering from cognitive decline and Alzheimer’s disease.
Scientists have also found significant improvement in Alzheimer’s patients by combining acetyl-L-carnitine with standard medications used in treating the disease. Researchers found a vastly improved response rate in patients taking acetyl-L-carnitine with their medication as opposed to those taking only their standard medication.20 This combination therapy is now being considered an improved management approach to the disease.
The good news continues, as other studies have found that acetyl-L-carnitine supplementation at doses of 1.5-3 grams daily for at least three months provided significant improvement for those with mild cognitive impairment as well as in people with Alzheimer’s.21 These promising findings indicate a role for acetyl-L-carnitine in slowing the cognitive decline associated with Alzheimer’s disease and boosting the effectiveness of prescription therapies.
Averting and Managing Depression
Aging and disease often bring on their own unique forms of depression. Scientists now understand the particular chemistry of these types of depression, and are finding that acetyl-L-carnitine actually improves the brain’s structure and function, which can help alleviate certain forms of depression.
For example, scientists examined two elderly depressed men and found large amounts of high-energy fat metabolites in their brains, indicating poor energy utilization by the brains’ own tissues. This failure of the brain to function optimally resulted in a chemically induced depression. When the men supplemented with acetyl-L-carnitine, the levels of these molecules fell and they experienced significant improvements in their depression rating scale.22
Depression often occurs in those suffering from illnesses such as cancer, diabetes, and heart disease. Sadly, this type of depression is often ignored by the medical profession, thereby increasing the patient’s suffering. A study published in 200423 showed that supplementing cancer patients with carnitine for just one week resulted in marked improvements in depression score, sleep disruption, and fatigue scores. Such quality-of-life improvements are critical and can make the difference between improvement and decline.
Recently, doctors tested acetyl-L-carnitine against the mood-stabilizing drug amisulpride.24 They found that acetyl-L-carnitine was just as effective as amisulpride in treating depression, without any of the drug’s side effects.
Alleviating Physical and Mental Fatigue
Fatigue is one of the most common complaints that doctors hear from their patients. Usually, doctors are at a loss as to the cause or the appropriate treatment. Because carnitine helps produce energy in brain tissue and muscle, it may well be of significant benefit for patients who suffer from fatigue.
Those suffering from multiple sclerosis often experience debilitating muscle fatigue. In an interesting three-month clinical trial, scientists compared the drug amantadine25 to acetyl-L-carnitine to see which was most effective in reducing fatigue. During the study, patients were switched to determine the most effective treatment. When the patients were evaluated, those using acetyl-L-carnitine scored much better on a scale of fatigue severity than those treated with amantadine. The investigators concluded that acetyl-L-carnitine was better tolerated and more effective than standard pharmaceutical therapy for fatigue related to multiple sclerosis. Acetyl-L-carnitine thus appears to help make muscle tissue more resistant to fatigue.
While the cause of chronic fatigue syndrome is not well understood, scientists believe the condition involves components of both the central nervous and neuromuscular systems. Both acetyl-L-carnitine and propionyl-L-carnitine show impressive results in reducing targeted areas of fatigue. Acetyl-L-carnitine significantly improves mental fatigue, while propionyl-L-carnitine more effectively manages general fatigue. In an open-label, randomized trial of acetyl-L-carnitine and propionyl-L-carnitine (at a dose of 2 grams per day), improvements were seen in 59% of acetyl-L-carnitine-supplemented patients and 63% of those receiving propionyl-L-carnitine.26 In both groups, attention improved, while fatigue worsened two weeks after treatment was halted.
These findings suggest that both acetyl-L-carnitine and propionyl-L-carnitine can help manage the symptoms of chronic fatigue syndrome. Furthermore, individuals may be able to manage their symptoms selectively by choosing the carnitine formulation that is best suited to their specific health concerns.
Protecting Against Painful Neuropathies
Damaged nerve cells contribute to a condition known as neuropathy, which can include symptoms such as pain, numbness, altered sensation, and muscle weakness. Neuropathy can be caused by various drugs,27,28 certain infectious agents, and metabolic conditions such as diabetes. Acetyl-L-carnitine appears to protect against development of neuropathy from many causes, and may even improve symptoms of these painful, debilitating conditions.
Drug-induced neuropathy is most common with certain cancer chemotherapy agents and some anti-retroviral drugs used to treat HIV/AIDS. In a 2003 study, acetyl-L-carnitine protected against the neuropathy commonly caused by cisplatin and paclitaxel, two frequently used chemotherapy drugs.29 In similar studies in 2005, daily treatment with acetyl-L-carnitine produced improvement in 73% of patients,30 as well as significantly better sensory and motor scores.27 Both groups of investigators recommended further testing and suggested that acetyl-L-carnitine has a role in both preventing and treating chemotherapy-induced neuropathy. Moreover, these and other studies have shown that the benefits of acetyl-L-carnitine occur without diminishing the anti-cancer effects of the drugs themselves.31
Drugs that are used to treat HIV/AIDS disrupt mitochondrial DNA synthesis, which may be one of the mechanisms behind the neuropathy associated with their use. Because carnitine levels are known to be low in patients receiving these drugs, scientists sought to determine whether supplements would offset these effects.32 In a 2004 study, acetyl-L-carnitine supplementation produced improvement in an impressive 76% of patients suffering from neuropathy related to HIV/AIDS medications.32
Unfortunately, many HIV patients discontinue their lifesaving medications because of the painful side effect of neuropathy. However, acetyl-L-carnitine may change all of that. In a promising study published in 2006, researchers demonstrated major reductions in pain intensity scores among patients who took their medications and supplemented with acetyl-L-carnitine at 2 grams per day for four weeks.33 Treatment at this dose level was well tolerated. The study suggests that supplementation with acetyl-L-carnitine could allow chronically ill patients to continue taking their medications without suffering many of the drugs’ painful side effects.
Diabetic neuropathy plagues thousands of older adults. In addition to being painful, it can also result in tissue damage to the extremities, which may result in amputation. Since its numerous causes include decreased carnitine levels and high production of free radicals in nerve cells,34 scientists have investigated managing diabetic neuropathy with carnitine supplementation.
In a long-term, randomized, controlled trial in patients with diabetic neuropathy in 2002, acetyl-L-carnitine treatment (daily injections of 1 gram for 10 days, followed by 2 grams per day taken orally for one year) produced notable improvements in nerve conduction velocity and pain compared to placebo.35 Another recent study found that in addition to pain relief among 1,257 patients receiving acetyl-L-carnitine, significant improvements were recorded in nerve fiber numbers and regenerating nerve fiber clusters in people with chronic diabetic neuropathy.36 These exciting results suggest that diabetic neuropathy and other forms of nerve injury may not be as irreversible as they have long been thought to be.
Additional benefits of acetyl-L-carnitine continue to be documented as scientists find new applications for this nutrient. One recent study found that acetyl-L-carnitine treatment helped to prevent nerve cell death, even in traumatically damaged nerve fibers.37 In another promising study, acetyl-L-carnitine improved the function of the specialized nerve cells that make up the retina, the part of the eye involved in visual perception. Individuals with age-related macular degeneration, a common cause of vision loss, received a combination of acetyl-L-carnitine, vitamin E, and other antioxidants, which led to improved function of the retinal nerve cells and slight improvements in visual function.38